4′epidoxorubicin (Epi DX) in elderly or unfit patients (pts) with small cell lung cancer (SCLC): a phase II experience by the EORTC Lung Cancer Cooperative Group

Abstract
No abstract available

This publication has 0 references indexed in Scilit: